Trial intelligence / Profile preview

Synthetic exosomes for periorbital rejuvenation

PACTR202510463370770Phase 0Recruiting

Sponsor
Cairo University
Start
Oct 2025
Countries
1
01

Overview

Phase 0, open-label trial in cutaneous aging, periorbital rhytides and None, sponsored by Cairo University. Primary endpoint: Primary efficacy of synthetic exosomes in periorbital rejuvenation. Started Oct 2025; status: recruiting.

02

Conditions

cutaneous agingperiorbital rhytides

Beyond the preview

Go deeper on PACTR202510463370770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202510463370770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call